Clinical Trial Update: Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial in colorectal cancer with liver metastases reports improved survival with a strategy of molecularly targeted chemotherapy plus liver resection in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Cancer with Liver Metastases

Snippet

Sponsor: EPS Corporation | Conditions: Liver Only Metastasis From KRAS Exon 2 Wild Type (Under Protocol 1.0-1.2 Edition) and RAS Wild Type (Under Protocol 2.0 Edition) Colorectal Cancer | Phase 2 | Status: COMPLETED